Zurueck zur Suche

Reporte zur Charge U019290

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 8 UT 2 GA 1 TN 1 CO 1 AR 1

VAERS 2583973

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u019290

schwer
Staat
UT
Alter
33,0
Geschlecht
F
Eingang
17.02.2023
Impfdatum
17.02.2023
Beginn
17.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Epistaxis Fall Loss of consciousness Pallor Speech disorder

Symptomtext

Patient received the sub-q vaccines first. The Adacel was administered and then the Twinrix. Patient was talking immediately prior to the Twinrix being given and during administration she began to make a strange sound. After administration was complete, patient then became unconscious and fell out of her chair. She was unconscious for at least 1 minute. She was moved to her back. She did have a bloody nose and was still not talking normal and had released her bladder. She was pale. Paramedics arrived and took her blood pressure and pulse. They put her back in the chair. They were going to perform her blood pressure again and were unable because the patient began to seize. The paramedics took her to the ER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
unknow
Allergien
none
Vorherige Impfungen
-

VAERS 2135035

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

moderat
Staat
UT
Alter
27,0
Geschlecht
F
Eingang
23.02.2022
Impfdatum
18.01.2022
Beginn
19.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Paraesthesia

Symptomtext

On 1/25/22, Patient contacted Nurse to report numbness and tingling to her L arm and right leg that started the day after receiving the listed 5 vaccinations. Nurse referred her to clinic. On 1/31/22 she had her first clinic visit where she was instructed to use ice 2-3 times per day, 15 min. at a time, home stretches, and follow up in 2 weeks. Regular duty. Second clinic visit on 2/7/22 added prednisone to the treatment regime with follow up in 10 days. Third clinic visit on 2/15/22 added Gabipentin and Physical Therapy

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None known
Aktuelle Erkrankungen
-
Vorgeschichte
Lyme Disease (10 Years ago),
Andere Medikamente
Spironolactone, Kylena IUD, Vitamin C
Allergien
Egg intolerance (Nausea/vomiting after consumption).
Vorherige Impfungen
-

VAERS 2622421

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

mild
Staat
TX
Alter
4,0
Geschlecht
M
Eingang
27.04.2023
Impfdatum
25.04.2023
Beginn
27.04.2023
Tage bis Beginn
2,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site erythema Injection site swelling Pain

Symptomtext

Patient had 4-year vaccines on 04/25/2023. Mom reports some redness and swelling to left leg started on Wednesday, April 04/26/2023 evening where patient received Kinrix and MMR. Patients swelling and redness worsened on Thursday, April 27, 2023, after school. Patient is able to ambulate but complains of pain. Afebrile.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None.
Vorgeschichte
Cerebellar hypoplasia, congenital dilation of the renal pelvis
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2562297

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

mild
Staat
TX
Alter
44,0
Geschlecht
M
Eingang
18.01.2023
Impfdatum
18.01.2023
Beginn
18.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Rash Rash macular

Symptomtext

Patient had allergic reaction in office after waiting his 15 mins. Patient was checking out and informed he was noticing a rash and red blotches on his arms. Patient was brought back to the clinic and he explined the rash on his arms was itchy and he was feeling itchy and tingling in his face. Patient denied shortness of breath, difficulty swallowing, and facial swelling. Patient was given 50ml of benadryl IM and waited an additional 20 minutes. After 20 minutes patient was notably improved and still had no complaints of difficulty breathing and swallowing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
no
Vorgeschichte
Thick blood
Andere Medikamente
Aspirin
Allergien
no
Vorherige Impfungen
-

VAERS 2462466

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u019290

mild
Staat
TX
Alter
1,1
Geschlecht
M
Eingang
27.09.2022
Impfdatum
15.09.2022
Beginn
26.09.2022
Tage bis Beginn
11,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash maculo-papular

Symptomtext

Maculopapular Rash through out body. Treatment: Cetirizine oral solution 2.5 ml daily Outcome: Stable Date of visit 9/27/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash maculo-papular
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Diaper Rash
Vorgeschichte
No
Andere Medikamente
Tylenol 160/5 3.75 ml
Allergien
NKA
Vorherige Impfungen
-

VAERS 2260459

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

mild
Staat
TX
Alter
17,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Rash Respiratory tract congestion

Symptomtext

Minor presented with congestion, itching and rash to neck and arms 1-2 hours after administration of 1st series vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2661507

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
27.07.2023
Impfdatum
18.07.2023
Beginn
18.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; Medical assistant reported expired MMRII vaccine administered to a patient.; This spontaneous report has been received from Medical Assistant, regarding to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and previous drugs reactions or allergies were not reported. On 18-JUL-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (Wistar RA 27-3) Virus Vaccine, Live (rHA) (M-M-R II) injection (lot number U019290 which has been verified to be valid, expiration date reported and validated as 18-JUN-2023), administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). No additional adverse events were reported in the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2652929

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

gering
Staat
GA
Alter
3,0
Geschlecht
U
Eingang
06.07.2023
Impfdatum
28.06.2023
Beginn
28.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No other AE; calling to report administration of an expired dose of MMR II to a patient. confirmed this was the first dose for the patient and no symptoms reported. No other AE and no PQC.; This spontaneous report was received from a medical assistant referring to a 3-year-old patient of unknown gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported. On 28-JUN-2023, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot number U019290, expiration date 18-JUN-2023 (dose and route of administration not provided) for prophylaxis (expired product administered). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2647969

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
26.06.2023
Impfdatum
20.06.2023
Beginn
20.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; Vaccine expired on 06/18/2023 and was administered on 06/20/2023.; This spontaneous report was received from a medical assistant, referring to patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. On 20-JUN-2023, the patient was vaccinated with first and expired dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) rHA injection (lot #U019290 was valid, expiration date not reported but upon internal reviewwas established as 18-JUN-2023, exact dose, route of administration and anatomical location were not provided) for prophylaxis (Expired vaccine used). Patient had not reported signs/symptoms of adverse effects. No additional adverse event (AE) (No adverse event) and product quality complaint (PQC).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2647969

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
26.06.2023
Impfdatum
20.06.2023
Beginn
20.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; Vaccine expired on 06/18/2023 and was administered on 06/20/2023.; This spontaneous report was received from a medical assistant, referring to patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. On 20-JUN-2023, the patient was vaccinated with first and expired dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) rHA injection (lot #U019290 was valid, expiration date not reported but upon internal reviewwas established as 18-JUN-2023, exact dose, route of administration and anatomical location were not provided) for prophylaxis (Expired vaccine used). Patient had not reported signs/symptoms of adverse effects. No additional adverse event (AE) (No adverse event) and product quality complaint (PQC).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2628031

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

gering
Staat
TN
Alter
5,0
Geschlecht
F
Eingang
05.05.2023
Impfdatum
04.05.2023
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Vaccine, pediarix, given was expired. Per manufacturer potency of vaccine is good for 30 days. Per CDC recommendations repeat as soon as possible.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2610068

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u019290

gering
Staat
CO
Alter
46,0
Geschlecht
F
Eingang
05.04.2023
Impfdatum
05.04.2023
Beginn
01.04.2023
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration

Symptomtext

Vaccine was administered as an intramuscular instead of subcutaneous.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2374953

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

gering
Staat
AR
Alter
4,0
Geschlecht
M
Eingang
20.07.2022
Impfdatum
20.07.2022
Beginn
20.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered

Symptomtext

Patient is a 4-year-old male who received a 5 to 11-year-old dose of the COVID-19 vaccine. We kept him here for 30 minutes. He was monitored during this time. Patient did not experience any symptoms of an adverse reaction. He was well appearing. Vitals stable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
No medical test performed.
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2369441

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019290

gering
Staat
TX
Alter
4,0
Geschlecht
F
Eingang
14.07.2022
Impfdatum
13.07.2022
Beginn
13.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Oedema Peripheral swelling

Symptomtext

Left leg swollen. Mom pressed down on leg & left indent. Mom states it started on evening of 7/13/22. Mom spoke with Nurse Practitioner on 7/14/22 around 4:30pm. She instructed mom to take her to the ER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oedema
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
-
Andere Medikamente
n/a
Allergien
NKDA
Vorherige Impfungen
-